Phase II Study of Combination of Nab-Paclitaxel and Gemcitabine for Relapsed Small Cell Lung Cancer (SCLC)

被引：1
|
作者：
Furqan, M. [1 ]
Zhang, J. [1 ]
Clamon, G. [1 ]
Abu-Hejleh, T. [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Med, Iowa City, IA 52242 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Gemcitabine; nab-paclitaxel; small cell lung cancer;
D O I：
10.1016/j.jtho.2018.08.1378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.12-02
引用
收藏
页码：S791 / S791
页数：1
相关论文
共 50 条
  • [31] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    BMC CANCER, 2017, 17
  • [32] Single-Arm Phase II Study of Nab-Paclitaxel for Patients with Chemorefractory Non-Small Cell Lung Cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S922 - S922
  • [33] Paclitaxel in combination with cisplatin, etoposide and thoracic radiotherapy for limited small cell lung cancer (SCLC). A phase II study
    Bremnes, RM
    Sundstrom, S
    Aasebo, U
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [34] Phase Ib/II study of ALT-803 in combination with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer.
    Acoba, Jared David
    Rock, Amy
    Wong, Hing C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [35] Phase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer.
    Pijnappel, Esther N.
    Wassenaar, Nienke P. M.
    Gurney-Champion, Oliver J.
    Klaassen, Remy
    van der Lee, Koen S.
    Pleunis-van Empel, Marjolein
    Richel, Dick J.
    Legdeur, Marie-Cecile J. C.
    Nederveen, Aart J.
    Van Laarhoven, Hanneke W. M.
    Wilmink, Johanna
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] A combination of gemeitabine and paclitaxel in patients with relapsed small-cell lung cancer: a phase II pilot study
    Dazzi, Claudio
    Cariello, Anna
    Casanova, Claudia
    Papiani, Giorgio
    Turolla, Gianni M.
    Tamberi, Stefano
    Papi, Maximilian
    Pasquini, Enzo
    Frassineti, Giovanni L.
    Vertogen, Bernadette
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S467 - S468
  • [37] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
    You, Min Su
    Ryu, Ji Kon
    Kang, Jinwoo
    Choi, Jin Ho
    Choi, Young Hoon
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285
  • [38] Gemcitabine and nab-paclitaxel combination therapy for the treatment of metastatic pancreatic cancer
    Sasaki, Takashi
    Kanata, Ryo
    Saito, Kei
    Yamada, Ikuhiro
    Matsuyama, Masato
    Ozaka, Masato
    Takano, Kouichi
    Sasahira, Naoki
    ANNALS OF ONCOLOGY, 2016, 27
  • [39] A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations
    Baik, Christina
    Goulart, Bernardo
    Nguyen, Katherine
    Lee, Sylvia
    Eaton, Keith
    Chow, Laura
    Rodriguez, Cristina
    Santana-Davila, Rafael
    Wood, Rebecca
    Martins, Renato
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1227 - S1227
  • [40] Phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer (SCLC)
    Han, J.
    Lim, K. Y.
    Kim, H. Y.
    Han, J. H.
    Oh, S. H.
    Yun, T.
    Kim, H. T.
    Lee, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345